CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-24 | LAROSA JOSEPH J EVP General Counsel and Secret | Shares withheld for taxes | −11,084 | $1,060.13 | $11.8M | 39,803 |
| 2024-06-24 | LAROSA JOSEPH J EVP General Counsel and Secret | Option exercise · Non-Qualified Stock Option (right to buy) | −14,450 | 14,450 | ||
| 2024-06-14 | BROWN MICHAEL S Director | Option exercise 10b5-1 | +1,535 | $625.60 | $960K | 2,917 |
| 2024-06-14 | BROWN MICHAEL S Director | Sale 10b5-1 | −1,535 | $1,040.00 | $1.6M | 1,382 |
| 2024-06-14 | BROWN MICHAEL S Director | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −1,535 | 0 | ||
| 2024-06-12 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Sale 10b5-1 | −14,879 | $1,015.30 | $15.1M | 40,255 |
| 2024-06-12 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Sale 10b5-1 | −270 | $1,016.62 | $274K | 39,985 |
| 2024-06-12 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Conversion 10b5-1 | +1,000 | 1,000 | ||
| 2024-06-12 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Sale 10b5-1 | −1,000 | $1,025.27 | $1.0M | 0 |
| 2024-06-12 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Conversion · Class A Stock 10b5-1 | −1,000 | 14,775 | ||
| 2024-06-11 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Sale 10b5-1 | −7,321 | $1,015.28 | $7.4M | 56,877 |
| 2024-06-11 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Sale 10b5-1 | −1,743 | $1,016.04 | $1.8M | 55,134 |
| 2024-06-10 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Gift | −75,799 | 0 | ||
| 2024-06-10 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Gift | +37,900 | 56,048 | ||
| 2024-06-10 | LAROSA JOSEPH J EVP General Counsel and Secret | Gift | −1,608 | 0 | ||
| 2024-06-06 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Sale 10b5-1 | −787 | $1,015.02 | $799K | 64,198 |
| 2024-06-05 | Bassler Bonnie L Director | Option exercise 10b5-1 | +827 | $380.95 | $315K | 2,209 |
| 2024-06-05 | Bassler Bonnie L Director | Sale 10b5-1 | −827 | $1,011.00 | $836K | 1,382 |
| 2024-06-05 | Bassler Bonnie L Director | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −827 | 0 | ||
| 2024-06-03 | McCourt Marion EVP Commercial | Option exercise 10b5-1 | +1,138 | $372.46 | $424K | 14,069 |
Page 25 of 49 · 971 trades